Kathryn Gregory

Kathryn Gregory

Director/Board Member presso DEVONIAN HEALTH GROUP INC.

Patrimonio netto: 17 221 $ in data 31/03/2024

62 anni
Health Technology
Consumer Services
Commercial Services

Profilo

Kathryn J.
Gregory
was the founder of Seneb Biosciences, Inc. (founded in 2009) where she held the title of Chief Executive & Business Officer from 2009 to 2017.
She currently holds the position of Independent Director at Carmell Corp., Director at Devonian Health Group, Inc. (since 2024), and Vice President & Head-Business Development at Antengene Corp.
Ltd.
(since 2021).
In her former roles, Ms. Gregory served as Executive Director-Business Development at Purdue Pharma LP (2015-2017), Associate Director-Business Development at Gensia Sicor Pharmaceuticals, Inc. (1988-1998), Director-Business Development at Cytel Corp.
(1998-1999), Vice President-Business Development & Licensing at Neose Technologies, Inc. (1999-2010), Vice President-Business Development at PhaseBio Pharmaceuticals, Inc., Chief Business Officer at Aileron Therapeutics, Inc., Head-Transactions at Shire Pharmaceuticals, Inc. (2012-2015), Head-North America Sourcing & Procurement at Teva Pharmaceuticals Ltd., Chief Business Officer at Avillion LLP (2017-2018), and President at Kg Biopharma Consulting LLC (2018-2019).
Ms. Gregory obtained an MBA from Pepperdine University and an undergraduate degree from the University of California, Berkeley.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
15/12/2023 6 727 ( 0.03% ) 17 221 $ 31/03/2024
28/02/2024 0 ( -.--% ) - $ 31/03/2024

Posizioni attive di Kathryn Gregory

SocietàPosizioneInizio
ANTENGENE CORPORATION LIMITED Corporate Officer/Principal 25/05/2021
CARMELL CORPORATION Director/Board Member -
DEVONIAN HEALTH GROUP INC. Director/Board Member 28/02/2024
Tutte le posizioni attive di Kathryn Gregory

Precedenti posizioni note di Kathryn Gregory

SocietàPosizioneFine
President 01/02/2019
Corporate Officer/Principal 01/02/2018
Seneb Biosciences, Inc. Chief Executive Officer 01/12/2017
Corporate Officer/Principal 01/03/2017
Corporate Officer/Principal 01/02/2015
Vedi nel dettaglio l'esperienza di Kathryn Gregory

Formazione di Kathryn Gregory

Pepperdine University Masters Business Admin
University of California, Berkeley Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Kathryn Gregory

Relazioni

90

Relazioni di 1° grado

16

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa4
PHASEBIO PHARMACEUTICALS, INC.

Health Technology

AILERON THERAPEUTICS, INC.

Health Technology

DEVONIAN HEALTH GROUP INC.

Health Technology

ANTENGENE CORPORATION LIMITED

Health Technology

Aziende private10

Health Technology

Health Technology

Health Technology

Gensia Sicor Pharmaceuticals, Inc.

Cytel Corp.

Health Technology

Health Technology

Seneb Biosciences, Inc.

Commercial Services

Carmell Therapeutics Corp.

Vedi le connessioni aziendali
  1. Borsa valori
  2. Insiders
  3. Kathryn Gregory